Editorial by Prof Nikolaos Papanikolaou, Scientific manager of the ProCAncer-I project ProCAncer-I is a collaborative project that combines the efforts of 20 clinical and technical partners in Europe and US. The focus is to collect the biggest in size, diverse dataset...
Newsletter #3
UC2: Characterization of cancer according to its biological aggressiveness
Βy Prof. Daniele Regge, Chief of the Radiology Unit, Candiolo Cancer Institute Patients diagnosed with localised prostate cancer (PCa) are classified in different risk groups, i.e. low, intermediate or high risk, and this choice will affect treatment and...
The Annotation tool
by Quibim Quibim set out to transform prostate diagnosis and monitoring by developing a new non-invasive imaging tool using MRI data and advanced computer models to investigate the prostate anatomy in extreme detail. The company has developed AI algorithms for...
Curating the data curation tool
by Advantis Medical Imaging Curating datasets is not an easy task. On the contrary, it can bring about hard-to-solve problems and lead to open-ended discussions, until a satisfactory solution is found. In ProCAncer-I, the curation of medical images has been a...
The largest collection of PCa multi-parametric anonymized image data worldwide
Interview with Prof Luis Martí-Bonmatí. Director of the Clinical Area of Medical Imaging Department at La Fe Polytechnic and University Hospital and Head of Radiology Department at QuironSalud Hospital in Valencia In ProCAncer-I you advertise that the platform that...
Advisory Board
Prof. Vincenzo Valentini is Professor of Radiation Oncology at the Faculty of Medicine of the Università Cattolica S.Cuore in Rome and Director of the Department of Radiology, Radiation Oncology and Haematology at the Policlinico Universitario A.Gemelli-IRCCS in Rome....
Presentation of partner QUIBIM, QUantitative Imaging Biomarkers In Medicine
Quibim is the go-to imaging partner bringing virtual biopsies to diagnostics and drug discovery. By following an AI-first approach to help detect pathologies and predict outcomes in oncology/immunotherapy, rheumatology and neurology. The company is specialized in...
Presentation of partner University of Pisa – The Imaging Lab
The University of Pisa is an Italian public research university located in Pisa, Italy. It was founded in 1343 by an edict of Pope Clement VI. It is the 19th oldest extant university in the world and the 10th oldest in Italy. The university is ranked within the top 10...
Presentation of partner Hacettepe University – Department of Radiology
The Radiology Department of the Hacettepe University is located in Ankara, Turkey. With decades of experience, all radiologic imaging procedures as well as interventional radiology services in scope of modern medicine are performed by the experienced and specialized...
Newsletter #3 Contents
Highlights

Diverging Visions of the Data-Value-Chain: The EHDS Proposal & the ProCAncer-I Project
Sep 21, 2023
Taking an innovative approach to applying artificial intelligence (AI) to medical imaging, Quibim is designing predictive panels to enable healthcare providers to improve patient outcomes.

ProCAncer-I at the IEEE EMBC 2023 in Sydney
Jul 28, 2023
Taking an innovative approach to applying artificial intelligence (AI) to medical imaging, Quibim is designing predictive panels to enable healthcare providers to improve patient outcomes.

Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer
Jul 24, 2023
Guerbet, a renowned global expert in medical imaging solutions and contrast media has announced the remarkable achievements of its teams in the PI-CAI Grand Challenge. This international challenge, organized by a consortium consisting of radiology opinion leaders,...

Second Dissemination Event of the ProCAncer-I Project in Lisbon
Jul 6, 2023
A great pleasure to have participated in the “AI and Machine Learning in Cancer Imaging 3.0 – Enhancing Healthcare through AI” event on 30th June & 1st July 2023 in Lisbon, Portugal